Name
Clinical Trial Agreement (CTA): Indemnification, Limitation of Liability, Subject Injury & Insurance
Date & Time
Sunday, April 12, 2026, 11:00 AM - 1:00 PM
Description
In Part II of the CTA Workshop, the speakers will dive into the critical components of a clinical trial agreement pertaining to the parties' liability, indemnification & subject injury reimbursement obligations, including a discussion around their typical insurance requirements, and how the parties' insurance coverage impacts their contractual obligations. The session will address the ethical basis for these requirements, best practices for balanced language and practical tools to effectively negotiate the most contentious provisions of a clinical trial agreement.
Speakers
• Lilith Mist - Exec. Clinical Research Director - Merck
• Peter Sullivan - Principal - Sullivan Group
• Caroline O'Hair - Partner - Lovell Law Group, PC
• Sarah Weissman - Associate Director, Clinical and Corporate Contracts - University of Pittsburgh
• Collin Gruener - Operations Manager, WCG Site Network - WCG
• Peter Sullivan - Principal - Sullivan Group
• Caroline O'Hair - Partner - Lovell Law Group, PC
• Sarah Weissman - Associate Director, Clinical and Corporate Contracts - University of Pittsburgh
• Collin Gruener - Operations Manager, WCG Site Network - WCG